Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/16357841

Download in:

View as

General Info

PMID
16357841